EVRX Signs Licensing Agreement For MoldRx

FARMINGDALE, NY--(BUSINESS WIRE)--Oct. 29, 2004--EnvironmentalRx (EVRX) continues to show growth in revenues. EVRX has multiple revenue streams produced from its diversified products and services. Patented Mold Remediation and Bio Terrorism kits are being sold to national store chains. Encapsulant 140 WP and Encapsulant are sold through exclusive dealerships for use in new construction and remediation. The educational division is ready to educate students for fulfilling state requirements for mold licenses. Remediation service calls are up.

EVRX subsidiary performed over $150,000 in remediation and air testing services in the last two quarters. The outlook is for the number to increase in the coming quarters. The newly signed contract for licensing and distribution of MoldRx, the brand name for Encapsulant 140 WP, is ear marked for encapsulating new home construction. The projection is $500,000 annually. This is based on the current the application in the remediation process and will be expanding in the construction industry. The upcoming Texas laws effective January 2005 will require education to qualify for State licensure. EVRX is providing copyrighted texts for classroom instruction. For every ten students revenue will be $7,500 per session. Classes are forming in Texas now and will be made available in each state as necessary. Further revenues streams including new products will be opening soon.

EnvironmentalRx is a multi faceted company that encompasses health-related services, indoor air quality, mold testing and remediation, products and information technology. The company is organized around indoor air quality, pollutant pathways and the methodology to overcome allergic, pathogenic and carcinogenic disease related to microorganisms. Each division is serviced will be serviced at the EVRX clinics springing up nationwide. The operation will encompass Conroe, Texas and Long Island, New York.

Except for historical information contained herein, the statements in this release are forward-looking statements that are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the companies' actual results in future periods to differ materially from forecasted results. Such risks and uncertainties include, but are not limited to, market conditions, competitive factors, the ability to successfully complete additional financings and other risks.

BACK TO INVESTOR RELATIONS